Yesterday’s MedHeads featured Stephanie Baum, Meghana Keshavan and Neil Versel speaking about a range of subjects including a University of Toronto spinout using computer modeling to predict disease and the debate over whether or not mobile health is actually dead.
Watch the broadcast above, but also take a look at the five important topics we reviewed this week.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Johnson & Johnson Health and Wellness Solutions, which focuses on behavior modification and consumer engagement through digital health coaching, has revealed a new product, My Health Discovery. It is a digital health assessment application provided through insurance companies and designed for users to have better success in improving their health.
2. Penn Medicine tests continuous, wearable patient monitoring
The University of Pennsylvania Health System has just kicked off its first-ever test of continuous, wearable patient monitoring, and the three-week pilot is being conducted with real inpatients in a hospital ward.
Monday, Penn Medicine launched a small-scale test of a wearable vitals monitor in a medical-surgical unit for cancer patients, Associate CIO Jim Beinlich confirmed to MedCity News. He said he was not allowed to name the technology vendor, but he said the monitors are FDA-approved hospital products, not consumer devices, and are worn on the arm.
A few months after the FDA cleared digital health company Propeller Health’ first collaboration with Boehringer Ingelheim Propeller Health remote monitoring platform for drug developers using its Respimat inhaler for people with chronic conditions, the FDA has cleared another company’s use of the Propeller platform — GlaxoSmithKline — according to a company statement.
4. Telepsychiatry business 1DocWay raises $1.7M to support expansion to 11 states
1DocWay, a company that combines telemedicine and psychiatry, has raised a new seed round to support the growth of its business from seven to 10 states. 1Doc Way has hired seven people to support the expansion. In an emailed response to questions, CEO and cofounder Samir Malik, said the $1.7 million will be used primarily across product support, sales and marketing.
5. Mass General to offer second opinions by telemedicine
Massachusetts General Hospital is getting ready to launch an online telemedicine service for patients to seek second opinions, the hospital’s telehealth chief said Tuesday.
The MGH-branded offering will debut at an undetermined time this fall, Sarah Sossong, director of Mass General TeleHealth, said at the mHealth + Telehealth World conference in Boston. Sossong told MedCity News that the yet-unnamed service would offer remote second opinions in multiple specialties, but would not comment further.
